Abstract. Cardiovascular disease is the leading cause of death in ESRD patients and is strongly associated with malnutrition. The mechanism of malnutrition is not clear, but hypermetabolism is suggested to contribute to cardiac cachexia. This study examined resting energy expenditure (REE) in relation to the clinical outcomes of ESRD patients who receive continuous ambulatory peritoneal dialysis (CAPD) treatment. A prospective observational cohort study was performed in 251 CAPD patients. REE was measured at study baseline using indirect calorimetry together with other clinical, nutritional, and dialysis parameters. Patients were followed up for a mean Ϯ SD duration of 28.7 Ϯ 14.3 mo. REE was 39.1 Ϯ 9.6 and 40.1 Ϯ 9.0 kcal/kg fat-free edema-free body mass per day for men and women, respectively (P ϭ 0.391). Using multiple regression analysis, fat-free edema-free body mass-adjusted REE was negatively associated with residual GFR (P Ͻ 0.001) and serum albumin (P ϭ 0.046) and positively associated with diabetes (P ϭ 0.002), cardiovascular disease (P ϭ 0.009), and C-reactive protein (P ϭ 0.009). At 2 yr, the overall survival was 63.3, 73.6, and 95.9% (P Ͻ 0.0001), and cardiovascular event-free survival was 72.3, 84.6, and 97.2% (P ϭ 0.0003), respectively, for patients in the upper, middle, and lower tertiles of REE. Adjusting for age, gender, diabetes, and cardiovascular disease, patients in the upper and middle tertiles showed a 4.19-fold (95% confidence interval, 2.15 to 8.16; P Ͻ 0.001) and a 2.90-fold (95% confidence interval, 1.49, 5.63; P ϭ 0.002) respective increase in the risk of all-cause mortality compared with those in the lower tertile. However, the significance of REE in predicting mortality was gradually reduced when additional adjustment was made for C-reactive protein, serum albumin, and residual GFR in a stepwise manner. In conclusion, a higher REE is associated with increased mortality and cardiovascular death in CAPD patients and is partly related to its close correlations with residual kidney function, cardiovascular disease, inflammation, and malnutrition in these patients.Malnutrition is usually the consequence of energy imbalance and can be attributed to changes in dietary intake or energy expenditure or both. Sustained hypermetabolism can lead to energy imbalance and wasting if not compensated for by an increase in energy intake. Indeed, hypermetabolism was suggested to be one of the contributory factors for cachexia in disease states such as cardiac failure (1), chronic obstructive pulmonary disease (2), and malignancy (3,4). However, its association with protein-energy malnutrition in ESRD patients has not been established. Protein-energy malnutrition is a significant complication and predicts mortality in ESRD patients (5,6). However, malnutrition is well known to be associated with inflammation and atherosclerotic vascular disease in ESRD patients (7,8). Whereas the severity of inflammation as denoted by the acute-phase response or proinflammatory cytokine is related to resting hypermetab...